CoChat

WISP1 Is a Novel Adipokine Linked to Inflammation in Obesity

Murahovschi, Veronica, Pivovarova, Olga, Ilkavets, Iryna, Dmitrieva, Renata M., Döcke, Stephanie, Keyhani-Nejad, Farnaz, Gögebakan, Özlem, Osterhoff, Martin, Kemper, Margrit, Hornemann, Silke, Markova, Mariya, Klöting, Nora, Stockmann, Martin, Weickert, Martin O., Lamounier-Zepter, Valeria, Neuhaus, Peter, Konradi, Alexandra, Dooley, Steven, von Loeffelholz, Christian, Blüher, Matthias, Pfeiffer, Andreas F.H., Rudovich, Natalia · 2015 · Diabetes
Cited by 130

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Abstract

WISP1 (Wnt1-inducible signaling pathway protein-1, also known as CCN4) is a member of the secreted extracellular matrix–associated proteins of the CCN family and a target gene of the Wingless-type (WNT) signaling pathway. Growing evidence links the WNT signaling pathway to the regulation of adipogenesis and low-grade inflammation in obesity. We aimed to validate WISP1 as a novel adipokine. Human adipocyte differentiation was associated with increased WISP1 expression and secretion. Stimulation of human macrophages with WISP1 led to a proinflammatory response. Circulating WISP1 and WISP1 subcutaneous adipose tissue expression were regulated by weight changes in humans and mice. WISP1 expression in visceral and subcutaneous fat tissue was associated with markers of insulin resistance and inflammation in glucose-tolerant subjects. In patients with nonalcoholic fatty liver disease, we found no correlation among disease activity score, liver fat content, and WISP1 expression. Insulin regulated WISP1 expression in adipocytes in vitro but had no acute effect on WISP1 gene expression in subcutaneous fat tissue in overweight subjects who had undergone hyperinsulinemic clamp experiments. The data suggest that WISP1 may play a role in linking obesity to inflammation and insulin resistance and could be a novel therapeutic target for obesity.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/db14-0444

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Cited by

See all 130

Metadata

Authors
Murahovschi, V., Pivovarova, O., Ilkavets, I., Dmitrieva, R. M., Döcke, S., Keyhani-Nejad, F., Gögebakan, Ö., Osterhoff, M., Kemper, M., Hornemann, S., Markova, M., Klöting, N., Stockmann, M., Weickert, M. O., Lamounier-Zepter, V., Neuhaus, P., Konradi, A., Dooley, S., von Loeffelholz, C., Blüher, M., Pfeiffer, A. F. H., & Rudovich, N.
Venue
Diabetes
Published
2014-10-03
Volume
64
Issue
3
Pages
856-866
ISSN
  • 0012-1797 (ISSN-L)
  • 1939-327X
OpenAlex
W2101492172
Cited by
130
References
9
FWCI
7.19
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: WISP1 Is a Novel Adipokine Linked to Inflammation in Obesity. https://app.cochat.ai/papers/10.2337/db14-0444
The paper
Murahovschi, V., Pivovarova, O., Ilkavets, I., Dmitrieva, R. M., Döcke, S., Keyhani-Nejad, F., Gögebakan, Ö., Osterhoff, M., Kemper, M., Hornemann, S., Markova, M., Klöting, N., Stockmann, M., Weickert, M. O., Lamounier-Zepter, V., Neuhaus, P., Konradi, A., Dooley, S., von Loeffelholz, C., . . . Rudovich, N. (2015). WISP1 Is a Novel Adipokine Linked to Inflammation in Obesity. Diabetes. https://doi.org/10.2337/db14-0444

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.